Exelixis Posts Q3 Revenue Rise

Nov 13, 2001

SAN FRANCISCO, Nov. 13 - Exelixis on Tuesday posted third-quarter revenues of $11.9 million versus $6.1 for the same quarter a year ago, the company announced.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

CMS 2018 PAMA Pricing Cut for Lab Tests Deeper Than Prior Estimate; Advanced Dx Lab Tests Fare Well
FDA Approves Merck's Keytruda, Agilent Dako CDx for Gastric Cancer Indications
In Brief This Week: Agilent, Edico Genome, Alere, and More
White Guinea Yam Genome Sequence Offers Insight Into Dioecy Plants
Signature Science Wins $2.9M IARPA Contract for Biological Threat Detection Computational Tools
People in the News: Olivier Elemento, Andrew Witty, Michael Korn, More

The Scan

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu